SAYAN, M. Et Al. 2020. NS5A resistance – associated substitutions in chronic hepatitis C patients with direct acting antiviral treatment failure in Turkey. International Journal of Infectious Diseases , vol.95 , 84-89.

SAYAN, M., Yıldırım, F. S., AKHAN, S., Yıldırım, A. A., ŞİRİN, G., ÇABALAK, M., ... Demir, M.(2020). NS5A resistance – associated substitutions in chronic hepatitis C patients with direct acting antiviral treatment failure in Turkey. International Journal of Infectious Diseases , vol.95, 84-89.

SAYAN, MURAT Et Al. "NS5A resistance – associated substitutions in chronic hepatitis C patients with direct acting antiviral treatment failure in Turkey," International Journal of Infectious Diseases , vol.95, 84-89, 2020

SAYAN, MURAT Et Al. "NS5A resistance – associated substitutions in chronic hepatitis C patients with direct acting antiviral treatment failure in Turkey." International Journal of Infectious Diseases , vol.95, pp.84-89, 2020

SAYAN, M. Et Al. (2020) . "NS5A resistance – associated substitutions in chronic hepatitis C patients with direct acting antiviral treatment failure in Turkey." International Journal of Infectious Diseases , vol.95, pp.84-89.

@article{article, author={MURAT SAYAN Et Al. }, title={NS5A resistance – associated substitutions in chronic hepatitis C patients with direct acting antiviral treatment failure in Turkey}, journal={International Journal of Infectious Diseases}, year=2020, pages={84-89} }